Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 18/20 | 0.49 |
| ▸ | FLT1 | P17948 | 1/20 | 0.40 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.40 |
| ▸ | EGLN2 | Q96KS0 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL966104 | 0.89 | EGLN1 (0.56) | EGLN1FLT1EGLN3EGLN2 | |
| SCHEMBL969590 | 0.84 | EGLN1 (0.58) | EGLN1FLT1EGLN3EGLN2 | |
| SCHEMBL4973349 | 0.84 | EGLN1 (0.51) | EGLN1EGLN2 | |
| SCHEMBL966893 | 0.75 | EGLN1 (0.57) | EGLN1 | |
| SCHEMBL965528 | 0.75 | EGLN1 (0.52) | EGLN1 | |
| SCHEMBL967008 | 0.75 | EGLN1 (0.56) | EGLN1FLT1EGLN3EGLN2 | |
| SCHEMBL966959 | 0.74 | EGLN1 (0.53) | EGLN1FLT1EGLN3 | |
| SCHEMBL967496 | 0.73 | EGLN1 (0.56) | EGLN1FLT1EGLN3EGLN2 | |
| SCHEMBL967699 | 0.73 | EGLN1 (0.50) | EGLN1FLT1EGLN3EGLN2 | |
| SCHEMBL1974053 | 0.72 | PTGS1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1866318-B1 | THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF | FIBROGEN INC (US) | 2011-06-22 | — | — | EP | disclosed |
| EP-1866318-A2 | THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF | FIBROGEN, INC. (US) | 2007-12-19 | — | — | EP | disclosed |
| WO-2006094292-A2 | THIENOPYRIDINE COMPOUNDS, AND METHODS OF USE THEREOF | FIBROGEN, INC. (US) | 2006-09-08 | — | — | WO | disclosed |